Taryn Zucker

Associate, New York

Biography

Overview

Taryn Zucker is an associate in the New York Capital Markets Practice concentrating on securities transactions and general corporate representations.

Taryn represents issuers and underwriters in equity and debt securities transactions. She has been the lead associate on a number of IPOs and also counsels public companies on disclosure issues, periodic filings and corporate governance practices.

Taryn often works with entrepreneurs and start-up companies as part of the Emerging Companies practice.

Bars and Courts
New York State Bar
Massachusetts State Bar
Education
JD
University of Pennsylvania Law School
BA
Brown University
Languages
English

Experience

Representation of Tufin Software Technologies, a provider of policy management software, in its $124 million IPO and listing on the NYSE. JPMorgan, Barclays and Jefferies acted as Bookrunners.

Representation of Goldman Sachs, JPMorgan and Citibank in the $1.4 billion IPO and listing on Nasdaq of StoneCo., a Brazilian payment systems company. Subsequently represented the underwriters in a follow-on offering by selling shareholders of the company.

Representation of Goldman Sachs, Barclays and Jefferies in the $73 million IPO and listing on Nasdaq of Mimecast, a leading provider of email continuity and security services. Subsequently represented the underwriters in a follow-on offering by selling shareholders of the company.

Representation Morgan Stanley and Credit Suisse, as joint lead bookrunners, in connection with the public offering and sale of $500 million pass through certificates of Delta Airlines.

Representation of Kornit Digital Ltd., a digital printing company, in connection with its $73 million IPO and listing on Nasdaq. Barclays and Citigroup acted as joint bookrunning managers.

Representation of CyberArk Software Ltd., a global cyber security company, in connection with its $99 million IPO and listing on Nasdaq. JPMorgan and Deutsche Bank acted as bookrunners.

Representation of Barclays and Cowen, as joint bookrunners in the $43 million IPO and listing on Nasdaq of Foamix Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing its proprietary minocycline foam for the treatment of acne, impetigo and other skin conditions.

Representation of Agricultural Bank of China, New York Branch, in the establishment of its $8 billion Section 4(a)(2) commercial paper program.